Heritage Cannabis Holdings Corp. (CSE:CANN) (CNSX.CANN.CN) (OTC:HERTF) (“Heritage” or the “Company”), a leading Canadian cannabis company is pleased to announce that its subsidiary Voyage Cannabis Corp. (“Voyage”) has been granted a cannabis oil sales license by Health Canada, effective April 8, 2020. This sales license will allow Voyage to begin selling cannabis products, including oil derivatives, to the Provincial cannabis boards as well as directly to patients in the medical market. The Company is developing a variety of products which it plans to market under brands that offer unique high quality properties and provide consumers with clear choices.
The Company plans to begin making its cannabis oil available for sale as soon as possible. Included in this offering will be its award-winning, direct-to-vape, all natural oil products. The Company’s proprietary extraction methodology uses high pressure systems and no harmful chemicals. Additionally, Heritage will launch various formulations of full spectrum CBD tinctures when product approval is received from Health Canada.
With the achievement of this sales license, the Company intends to further discussions to create joint ventures with companies which have distinct cannabis products that can be formulated at a Heritage facility and mutually marketed to Canadian consumers.
“We are extremely excited for Voyage to receive this sales license. It is a significant development allowing us to begin selling cannabis oil to the Canadian retail market. We have been processing and formulating products in anticipation of this license and are eager to begin offering them to the public.” stated Clint Sharples, CEO of Heritage. “High quality cannabis oil products are in great demand and we are confident that our customers will appreciate the value in the products we will be bringing to market. Our extraction division, Purefarma, has built a reputation for quality and purity, and this license allows Voyage to offer these products directly to this growing market in addition to our contract manufacturing business.”
About Heritage Cannabis Holdings Corp.
Heritage Cannabis currently has two Health Canada approved licenced producers through its subsidiaries Voyage Cannabis Corp. and CannaCure Corp., both regulated under the Cannabis Act Regulations. Working under these two licences, Heritage has two additional subsidiaries, Purefarma Solutions, which provides extraction services, and a Medical Services Division which is focused on cannabis based medical solutions. Heritage as the parent company, is focused on providing the resources for its subsidiaries to advance their products or services to compete both domestically and internationally.
ON BEHALF OF THE BOARD OF DIRECTORS OF HERITAGE CANNABIS HOLDINGS CORP.
For more information contact:
The Canadian Stock Exchange does not accept responsibility for the adequacy or accuracy of this release.
This news release contains forward-looking information, which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectation. Important factors – including the availability of funds, the results of financing efforts, the results of exploration activities — that could cause actual results to differ materially from the Company’s expectations are disclosed in the Company’s documents filed from time to time on SEDAR (see www.sedar.com). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).